Improving balance in Parkinson's disease using blood flow restriction
Official title: Blood Flow Restriction for Optimizing Balance in Parkinson's Disease
Run by The University of Texas Health Science Center at San Antonio · NCT06508801 · Data updated 2026-11-12
This study is testing whether using blood flow restriction during balance exercises can help people with Parkinson's disease improve their walking, balance, and endurance.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 85 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | The University of Texas Health Science Center at San Antonio Academic / other |
| Locations | 1 site (San Antonio, Texas) |
| Status | Recruiting |
| Started | January 7, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | March 31, 2026 |
| Trial ID | NCT06508801 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are males and females aged 40-85 with a diagnosis of idiopathic Parkinson's disease in Hoehn and Yahr stages 2-4.
✕Probably not a fit
Patients with a history of cardiovascular disease, uncontrolled hypertension, or other significant neurological disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of blood flow restriction (BFR) during balance-challenging strengthening exercises, known as instability resistance training (IRT), on individuals with Parkinson's disease. Participants will be divided into two groups: one performing IRT with BFR and the other performing IRT without BFR. Each session will last approximately 45 minutes, and researchers will assess improvements in walking ability, balance, and endurance. Additionally, non-invasive peripheral nerve stimulation techniques will be used to measure spinal excitability in participants.
Why it matters
Potential benefit: If successful, this approach could enhance balance, mobility, and overall physical function in patients with Parkinson's disease.
How similar studies have gone: While the specific combination of BFR and IRT in Parkinson's disease is novel, similar approaches have shown promise in other populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Males and females between the ages 40 - 85 with a diagnosis of idiopathic Parkinson's Disease (PD) consistent with the United Kingdom PD society brain bank criteria, 2. in Hoehn and Yahr stage 2-4, 3. a score of ≥23 on the mini-Mental Scale Examination. Exclusion Criteria: 1. History of cardiovascular disease, uncontrolled hypertension (blood pressure ≥140/90 mmHg), orthostatic hypotension, deep-vein thrombosis, varicose veins, or rhabdomyolysis; 2. Ankle branchial index ≤ 0.9 or \> 1.3. 3. History of other neurological disorders affecting the central nervous system such as stroke, multiple sclerosis, tumors, amyotrophic lateral sclerosis or muscle disease such as muscular dystrophy, myopathy. 4. History of uncontrolled diabetes, severe osteoporosis, or cognitive impairment. 5. Body mass index above 40; such individuals are more likely to have poorer muscle function and more pain. 6. Absolute contraindications to exercise as per the American College of Sports Medicine (uncontrolled arrhythmias, third-degree heart block, recent electrocardiogram (EKG) changes, unstable angina, acute myocardial infarction, or acute congestive heart failure 7. Had surgery in the lower extremities within the past 6 months. 8. Pre-menopausal and not on birth control 9. Pregnant or planning to become pregnant within the course of the study 10. Plan to have major surgery within 2 months.
Where it's running
-
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States Recruiting
Study contacts
- Principal investigator: Anjali Sivaramakrishnan, PhD, PT — The University of Texas Health Science Center at San Antonio
- Study coordinator: Anjali Sivaramakrishnan, PhD, PT
- Email: sivaramakris@uthscsa.edu
- Phone: 210-567-8626
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
MAO-B PET/CT imaging in Parkinson’s-related diseases
This study tests whether 18F-FPyCO/SMBT-1 PET/CT can help diagnose Parkinson’s-related conditions by measuring lesion uptake in patients with PD, PD dementia, or parkinsonism.
-
Sleep and DBS: Testing Deep Brain Stimulation Effects on Sleep in Parkinson’s
This study tests how turning the Deep Brain Stimulation device on or off affects sleep quality in people with Parkinson’s who already have a DBS implant.
-
Detecting phosphorylated alpha-synuclein in colon tissue to help diagnose Parkinson's
This study will test whether routine colonoscopy tissue samples from adults with Parkinson's show phosphorylated alpha-synuclein, a protein linked to the disease.
-
tDCS to improve swallowing in Parkinson's disease
This study tests whether adding transcranial direct current stimulation (tDCS) to standard swallowing therapy helps people with Parkinson's disease who have dysphagia.
-
Investigating how deep brain stimulation affects sleep in Parkinson's disease
This study is testing how deep brain stimulation affects sleep in people with Parkinson's disease to see if it can help improve their sleep quality.
-
Using deep brain stimulation to treat cognitive dysfunction in Parkinson's disease
This study is testing if deep brain stimulation can help improve memory and thinking skills in people with Parkinson's disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.